Ferritic nitrocarburising of tool steels

Four different tool steel materials, P20, H13, M2 and D2, were nitrocarburised at 570&deg;C in a fluidised bed furnace. The reactive diffusion of nitrogen and carbon into the various substrate microstructures is compared and related to the different alloy carbide distributions. The effect of carbon bearing gas (carbon dioxide, natural gas) on carbon absorption is reported, as well as its influence on compound layer growth and porosity. Partial reduction of Fe3O4 at the surface resulted in the formation of a complex, epsi-nitride containing oxide layer. In H13, carbon was deeply absorbed throughout the entire diffusion zone, affecting the growth of grain boundary cementite, nitrogen diffusivity and the sharpness of the compound layer: diffusion zone interface. When natural gas was used, carbon became highly concentrated in the compound layer, while surface decarburisation occurred with carbon dioxide. These microstructural effects are discussed in relation to hardness profiles, and compound layer hardness and ductility. The surfaces were characterised using glow discharge optical emission spectroscopy, optical and scanning electron microscopy and X-ray diffraction.<br /

Pin on disc wear investigation of nitrocarburised H13 tool steel

Nitrocarburised H13 disks were tested in dry, sliding wear against a stationary ruby ball (pin). Three different 4 h nitrocarburising treatments were compared, using N2/NH3/CO2, N2/NH3/natural gas and N2/NH3 gas mixtures, resulting in compound layers of varying thickness, hardness, porosity and oxide morphology. During mild, oxidative wear, with the formation of abrasive wear debris, the most brittle and oxidised surfaces performed poorly. Polishing to a bright, reflective finish greatly reduced wear. However, the N2/NH3/CO2 sample also frequently maintained a \u27very mild\u27 wear regime, owing to the formation of a protective film between the wear surfaces, and resulting in a lowering of the friction coefficient. This treated surface was porous and covered in a complex layer of coarse oxide+epsi-carbonitride. Nitrocarburised samples and wear tracks were characterised by optical microscopy, SEM, atomic force microscopy and stylus profilometry.<br /

Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias

Robert Clarke and colleagues conduct a meta-analysis of unpublished datasets to examine the causal relationship between elevation of homocysteine levels in the blood and the risk of coronary heart disease. Their data suggest that an increase in homocysteine levels is not likely to result in an increase in risk of coronary heart disease

Cardiovasc Diabetol

Lower-extremity arterial disease (LEAD) is a major endemic disease with an alarming increased prevalence worldwide. It is a common and severe condition with excess risk of major cardiovascular events and death. It also leads to a high rate of lower-limb adverse events and non-traumatic amputation. The American Diabetes Association recommends a widespread medical history and clinical examination to screen for LEAD. The ankle brachial index (ABI) is the first non-invasive tool recommended to diagnose LEAD although its variable performance in patients with diabetes. The performance of ABI is particularly affected by the presence of peripheral neuropathy, medial arterial calcification, and incompressible arteries. There is no strong evidence today to support an alternative test for LEAD diagnosis in these conditions. The management of LEAD requires a strict control of cardiovascular risk factors including diabetes, hypertension, and dyslipidaemia. The benefit of intensive versus standard glucose control on the risk of LEAD has not been clearly established. Antihypertensive, lipid-lowering, and antiplatelet agents are obviously worthfull to reduce major cardiovascular adverse events, but few randomised controlled trials (RCTs) have evaluated the benefits of these treatments in terms of LEAD and its related adverse events. Smoking cessation, physical activity, supervised walking rehabilitation and healthy diet are also crucial in LEAD management. Several advances have been achieved in endovascular and surgical revascularization procedures, with obvious improvement in LEAD management. The revascularization strategy should take into account several factors including anatomical localizations of lesions, medical history of each patients and operator experience. Further studies, especially RCTs, are needed to evaluate the interest of different therapeutic strategies on the occurrence and progression of LEAD and its related adverse events in patients with diabetes

Correction to: Cluster identification, selection, and description in Cluster randomized crossover trials: the PREP-IT trials

An amendment to this paper has been published and can be accessed via the original article